Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02824575 |
|---|---|
| Brief Title: | Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer |
| First Submitted : | June 28, 2016 |
| First Submitted that Met QC Criteria : | July 1, 2016 |
| First Posted : | July 6, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 3, 2020 |
| Last Update Posted : | June 5, 2020 |